Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global IV and Oral...
-
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Global Genetic Disorders Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.The...
-
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Global Genetic Disorders Partnering 2015-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Global Genetic Disorders Partnering 2014-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
-
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021" report has been added to...
-
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021" report has been added to ResearchAndMarkets.com's...
-
Dublin, March 26, 2021 (GLOBE NEWSWIRE) -- The "Global Orphan Diseases Partnering 2010-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Partnering Terms and Agreements 2017-2021" report has been added to ResearchAndMarkets.com's offering. The Global Pharmaceutical...
-
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Specialty Pharmaceutical Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global...
-
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Genetic Disorders Partnering 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...